VOSSY yields 1.26% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, VOSSY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VOSSY + JNJ for your $10,000?
Vossloh AG manufactures and markets rail infrastructure products and services worldwide. It operates through three divisions: Core Components, Customized Modules, and Lifecycle Solutions. The Core Components division develops, produces, and markets rail fastening systems for light-rail, heavy-haul, and high-speed lines, as well as urban transport. This division also manufactures concrete rail ties, switch ties, and concrete low-vibration blocks for slab tracks and crossing panels. The Customized Modules division manufactures, installs, and maintains switches and crossings, as well as related control and monitoring systems for light-rail and high-speed applications. The Lifecycle Solutions division engages in rail trading, long-rail unloading at construction sites, welding new rails, reconditioning old rails, on-site welding, rail replacement, rail grinding/milling, rail inspection, and construction site supervision activities. This division also organizes and monitors rail shipments to construction sites; and enables on-site availability of the unloading systems. The company was founded in 1883 and is based in Werdohl, Germany.
Full VOSSY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.